EUVIMEDEUVIMED entdecken
Open Access

BRAF-activated ARSI suppressed EREG-mediated ferroptosis to promote BRAF V600E (mutant) papillary thyroid carcinoma progression and sorafenib resistance

Xing Chen, Xiang Chen, Wenjun Xie, Hua Ge, Hongyan He, Ailong Zhang, Junjie Zheng

International Journal of Biological Sciences · 01.01.2025 · 21 (1) · 128-142

DOI: 10.7150/ijbs.99423 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Biological Sciences, erschienen am 01.01.2025. Verfasst von Xing Chen und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thyroid and Hernia Surgery, Shengli Clinical Medical College of Fujian Medical University, Fujian Provincial Hospital, Fuzhou Universit…. Hauptthemen laut MEDLINE: Ferroptosis, Sorafenib, Proto-Oncogene Proteins B-raf, Thyroid Cancer, Papillary. Die Arbeit wurde bisher 11-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FerroptosisSorafenibProto-Oncogene Proteins B-rafThyroid Cancer, PapillaryThyroid NeoplasmsHumansAnimalsMiceCell Line, TumorDrug Resistance, NeoplasmMice, NudeMutationFemaleMale

Stichwörter der Autor:innen

ARSIBRAFEREGPTCferroptosis

Substanzen

SorafenibProto-Oncogene Proteins B-rafBRAF protein, human

Autor:innen und Institutionen

  • Department of Thyroid and Hernia Surgery, Shengli Clinical Medical College of Fujian Medical University, Fujian Provincial Hospital, Fuzhou University Affiliated Provincial Hospital, Fuzhou City, Fujian Province 350001,…
  • Department of Ultrasonography, Shengli Clinical Medical College of Fujian Medical University, Fujian Provincial Hospital, Fuzhou University Affiliated Provincial Hospital, Fuzhou City, Fujian Province 350001, China.
  • Department of Nuclear Medicine, Shengli Clinical Medical College of Fujian Medical University, Fujian Provincial Hospital, Fuzhou University Affiliated Provincial Hospital, Fuzhou City, Fujian Province 350001, China.
  • Department of Pathology, Shengli Clinical Medical College of Fujian Medical University, Fujian Provincial Hospital, Fuzhou University Affiliated Provincial Hospital, Fuzhou City, Fujian Province 350001, China.

Zitieren

APA

Chen, X., Chen, X., Xie, W., Ge, H., He, H., Zhang, A., & Zheng, J. (2025). BRAF-activated ARSI suppressed EREG-mediated ferroptosis to promote BRAF V600E (mutant) papillary thyroid carcinoma progression and sorafenib resistance. International Journal of Biological Sciences, 21(1), 128-142. https://doi.org/10.7150/ijbs.99423

Vancouver

Chen X, Chen X, Xie W, Ge H, He H, Zhang A, et al. BRAF-activated ARSI suppressed EREG-mediated ferroptosis to promote BRAF V600E (mutant) papillary thyroid carcinoma progression and sorafenib resistance. International Journal of Biological Sciences. 2025;21(1):128-142. doi:10.7150/ijbs.99423

BibTeX
@article{Chen2025,
  author = {Chen, Xing and Chen, Xiang and Xie, Wenjun and Ge, Hua and He, Hongyan and Zhang, Ailong and Zheng, Junjie},
  title = {BRAF-activated ARSI suppressed EREG-mediated ferroptosis to promote BRAF V600E (mutant) papillary thyroid carcinoma progression and sorafenib resistance},
  journal = {International Journal of Biological Sciences},
  year = {2025},
  volume = {21},
  number = {1},
  pages = {128--142},
  doi = {10.7150/ijbs.99423}
}
Kostenlos starten →